Wall Street analyst estimates for Doximity, Inc. (DOCS): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers.
Consensus price target
$27.73 (-19 % vs price $34.25)
between $18.00 and $41.00 · 7 targets published in the last quarter
Closing price, Oct 28
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2027E | $678M | $666M – $683M | $1.35 | 12 |
| 2028E | $722M | $705M – $743M | $1.56 | 10 |
Fiscal year ending in March · figures in USD · consensus as of October 29, 2026
Analyst Consensus
| Strong Buy | 1 |
| Buy | 8 |
| Hold | 13 |
| Sell | 2 |
| Strong Sell | 0 |
| Total analysts | 24 |
| Avg rating (−2 sell to +2 buy) | 0.33 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-05 | $0.35 | ||
| 2026-08-06 | $0.29 | $0.30 | -4.3% |
| 2026-05-13 | $0.26 | $0.28 | -7.1% |
| 2026-02-05 | $0.46 | $0.44 | +4.5% |
| 2025-11-06 | $0.45 | $0.38 | +18.8% |
| 2025-08-07 | $0.36 | $0.30 | +19.4% |
| 2025-05-15 | $0.38 | $0.27 | +39.9% |
| 2025-02-06 | $0.45 | $0.31 | +45.2% |
Valuation Ratios
| P/E Ratio | 40.29 |
| Price / Book | 6.83 |
| EV / EBITDA | 24.13 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $85.7M | $116.4M | $206.9M | $343.5M | $419.1M | $475.4M | $570.4M | $644.9M |
| Cost of Revenue | $10.9M | $14.9M | $31.2M | $39.8M | $53.5M | $50.7M | $55.9M | $70.3M |
| Gross Profit | $74.8M | $101.5M | $175.7M | $303.8M | $365.6M | $424.8M | $514.5M | $574.5M |
| Research & Development | $27.5M | $32.4M | $43.9M | $62.4M | $80.2M | $82.0M | $93.0M | $130.7M |
| Selling, General & Admin | $40.4M | $46.9M | $78.5M | $127.9M | $160.3M | $171.0M | $191.4M | $228.9M |
| Operating Expenses | $67.9M | $79.3M | $122.4M | $190.2M | $240.5M | $260.9M | $286.7M | $359.6M |
| Operating Income | $6.9M | $22.2M | $53.3M | $113.5M | $125.1M | $163.9M | $227.8M | $214.9M |
| EBITDA | $7.5M | $23.1M | $57.5M | $119.0M | $143.4M | $182.1M | $240.8M | $264.4M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-tax Income | $7.9M | $23.5M | $57.8M | $114.0M | $133.2M | $185.2M | $263.6M | $250.0M |
| Income Tax | $98,000 | -$6.2M | $7.6M | -$40.8M | $20.3M | $37.6M | $40.4M | $54.0M |
| Net Income | $7.8M | $29.7M | $50.2M | $154.8M | $112.8M | $147.6M | $223.2M | $196.1M |
| EPS | $0.00 | $0.06 | $0.12 | $0.81 | $0.58 | $0.78 | $1.19 | $1.05 |
| EPS (Diluted) | $0.00 | $0.06 | $0.12 | $0.70 | $0.53 | $0.72 | $1.11 | $0.98 |
| Shares Outstanding (Diluted) | 181.7 M | 181.7 M | 178.2 M | 191.0 M | 213.4 M | 205.7 M | 201.2 M | 199.0 M |
Price
| Price | $34.25 (closing price, October 28, 2026) |
| Market Cap | $6.1B |
| Exchange | NYSE |
| Country | US |
Related companies: VTRS · COO · GH · ICLR · TEM · HQY · SOLV · EHC
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of DOCS: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks